Gabapentin and Intervertebral disc degeneration - a phase IV clinical study of FDA data
We study 292,819 people who have side effects when taking Gabapentin. Intervertebral disc degeneration is found, especially among people who are female, 60+ old, have been taking the drug for < 1 month, also take Zometa and have Rheumatoid arthritis.
The phase IV clinical study analyzes which people take Gabapentin and have Intervertebral disc degeneration. It is created by eHealthMe based on reports from the FDA, and is updated regularly. You may use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
292,819 people reported to have side effects when taking Gabapentin.
Among them, 1,225 people (0.42%) have Intervertebral disc degeneration.
What is Gabapentin?
Gabapentin has active ingredients of gabapentin. It is used in neuralgia. Currently, eHealthMe is studying from 302,044 Gabapentin users.
What is Intervertebral disc degeneration?
Intervertebral disc degeneration (spinal disc degeneration) is found to be associated with 2,189 drugs and 1,428 conditions by eHealthMe. Currently, we are studying 19,358 people who have Intervertebral disc degeneration.
Number of Gabapentin and Intervertebral disc degeneration reports submitted per year:
Time on Gabapentin when people have Intervertebral disc degeneration *:
Gender of people who have Intervertebral disc degeneration when taking Gabapentin*:
Age of people who have Intervertebral disc degeneration when taking Gabapentin *:
Common drugs people take besides Gabapentin *:
Common side effects people have besides Intervertebral disc degeneration *:
Common conditions people have *:
* Approximation only. Some reports may have incomplete information.
Do you take Gabapentin and have Intervertebral disc degeneration?Check whether Intervertebral disc degeneration is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related publications that referenced our studies
- de Landaluce, L. O., Carbonell, P., Asensio, C., Escoda, N., López, P., & Laporte, J. R. , "Gabapentin and Pregabalin and Risk of Atrial Fibrillation in the Elderly: A Population-Based Cohort Study in an Electronic Prescription Database", Drug safety, 2018 Jan .
- Scarff JR, "The Potential for Somnambulism Associated with Gabapentin", The Internet Journal of Psychiatry, 2014 Jan .
Gabapentin side effects by duration, gender and age:
- Gabapentin side effects (302,044 reports)
Intervertebral disc degeneration treatments and more:
- Intervertebral disc degeneration (19,358 reports)
Common drugs associated with Intervertebral disc degeneration:
- Fosamax: 3,044 reports
- Zometa: 2,149 reports
- Prednisone: 1,834 reports
- Aspirin: 1,524 reports
- Aredia: 1,331 reports
- Humira: 1,329 reports
- Gabapentin: 1,225 reports
- Methotrexate: 1,079 reports
- Vioxx: 1,074 reports
- Celebrex: 1,013 reports
All the drugs that are associated with Intervertebral disc degeneration:
- Intervertebral disc degeneration (2,189 drugs)
Common conditions associated with Intervertebral disc degeneration:
- Osteoporosis: 2,563 reports
- Rheumatoid arthritis: 1,474 reports
- Pain: 1,188 reports
- High blood pressure: 964 reports
- Multiple sclerosis: 944 reports
All the conditions that are associated with Intervertebral disc degeneration:
- Intervertebral disc degeneration (1,428 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on gabapentin (the active ingredients of Gabapentin) and Gabapentin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Pepcid and Diabetes Insipidus - 10 seconds ago
- Ivermectin and Oxycodone drug interaction - 10 seconds ago
- Ozempic and Budesonide drug interaction - 15 seconds ago
- Artane and Azilect drug interaction - 32 seconds ago
- Clonidine and Magnesium Glycinate drug interaction - 36 seconds ago
- Bromocriptine Mesylate and Invega Sustenna drug interaction - 46 seconds ago
- Avonex and Bedwetting - 46 seconds ago
- Tramadol Hydrochloride and Gastroenteritis - 50 seconds ago
- Dilaudid and Sodium Bicarbonate In Plastic Container drug interaction - 51 seconds ago
- Enbrel and Eye Pain - 57 seconds ago